Cargando…
Peripartum management of patient with long QT3 after successful implantable cardioverter defibrillator device discharge resulting in device failure: a case report
BACKGROUND: Long QT3 syndrome type 3 (LQT3) is a gain of function mutation of the SCN5A gene that is inherited in an autosomal dominant fashion. Long QT3 syndrome type 3 results in an increase in arrhythmic events during rest, sleep, and bradycardia by extending the QT interval and inducing Torsades...
Autores principales: | Lee, Melissa J, Monteil, Danielle C, Spooner, Michael T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672658/ https://www.ncbi.nlm.nih.gov/pubmed/34926986 http://dx.doi.org/10.1093/ehjcr/ytab487 |
Ejemplares similares
-
Outcome by Sex in Patients With Long QT Syndrome With an Implantable Cardioverter Defibrillator
por: Younis, Arwa, et al.
Publicado: (2020) -
Validity of device-measured activity in patients with an implantable cardioverter-defibrillator
por: Kolk, M Z H, et al.
Publicado: (2023) -
BAYESIAN META-ANALYSIS ON MEDICAL DEVICES: APPLICATION TO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
por: Youn, Ji-Hee, et al.
Publicado: (2012) -
Successful management of wound dehiscence after implantation of a subcutaneous implantable cardioverter-defibrillator without device removal
por: Fukata, Mitsuhiro, et al.
Publicado: (2017) -
Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome
por: Sugiyama, Hirotaro, et al.
Publicado: (2017)